Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +1.42% slipped 2.00% to $307.33 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.13% rising 1.57% to 14,498.88 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.18% rising 1.62% to 34,511.99. The stock's fall snapped a four-day winning streak. Moderna Inc. closed $10.55 short of its 52-week high ($317.88), which the company reached on July 19th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.29% rose 0.55% to $116.05, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.35% rose 0.06% to $246.89, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.27% rose 1.88% to $57.54. Trading volume (109.4 M) eclipsed its 50-day average volume of 9.1 M.